scispace - formally typeset
Journal ArticleDOI

Quantification of 3-hydroxykynurenine in brain by high-performance liquid chromatography and electrochemical detection.

About
This article is published in Journal of Chromatography B: Biomedical Sciences and Applications.The article was published on 1988-01-01. It has received 71 citations till now. The article focuses on the topics: High-performance liquid chromatography.

read more

Citations
More filters
Journal ArticleDOI

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.

TL;DR: It is concluded that inflammatory diseases are associated with accumulation of QUIN, kynurenic acid and L-kynurenine within the central nervous system, but that the available data do not support a role for QUIN in the aetiology of Huntington's disease or Alzheimer's disease.
Journal ArticleDOI

Increased cortical kynurenate content in schizophrenia.

TL;DR: In rats, chronic treatment with haloperidol did not cause an increase in kynurenate levels in the frontal cortex, indicating that the elevation observed in schizophrenia is not due to antipsychotic medication.
Journal ArticleDOI

Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid.

TL;DR: Because kynurenic acid is an endogenous inhibitor of excitatory neurotransmission and can block excitotoxic degeneration in vivo, a relative deficiency of this compound could directly contribute to neuronal degenerations in HD.
Journal ArticleDOI

Impaired Kynurenine Pathway Metabolism in The Prefrontal Cortex of Individuals With Schizophrenia

TL;DR: The present results further support the hypothesis that the normalization of cortical KP metabolism may constitute an effective new treatment strategy in SZ.
Journal ArticleDOI

Kynurenine and its metabolites in Alzheimer's disease patients

TL;DR: Examination of peripheral KP in patients with Alzheimer type dementia proves activation of peripheral kynurenine pathway in this type of dementia and offers Novel therapeutic opportunities, with the development of new compounds as a promising perspective for brain neuroprotection.
References
More filters
Journal ArticleDOI

Protection against chemically induced seizures by 2-amino-7-phosphonoheptanoic acid

TL;DR: It is proposed that an aspartergic component may contribute to the development of convulsions after 3MPA, TSC, DMCM and picrotoxin.
Journal ArticleDOI

SYNTHESIS AND METABOLISM OF l‐KYNURENINE IN RAT BRAIN

TL;DR: Kynurenine was formed from tryptophan in brain and was also taken up from the periphery, and kynuramine levels in different areas of the brain were similar to those of tryptamine.
Journal ArticleDOI

Convulsant action of intracerebroventricularly administered l-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships

I.P. Lapin
- 01 Dec 1982 - 
TL;DR: Succinic acid, and the derivatives which have been tested, as well as l-kynurenine sulphate and quinolinic acid, injected into the brain ventricles in mice, induced clonic seizures.
Journal ArticleDOI

Effects of vitamin B-6 deficiency and tryptophan loading on urinary excretion of tryptophan metabolites in mammals

TL;DR: Levels of urinary metabolites reached a maximum in guinea pigs after only 1 week of consuming the vitamin B-6 deficient diet, suggesting that the vitamin deficiency developed very rapidly in this species.
Related Papers (5)